Purchase Order 75N91024P00129
Award Date 12/15/23
Potential Completion Date 12/14/24
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the National Institutes of Health, to Molecular Devices LLC, a for-profit limited liability company and subsidiary of Danaher Corporation. The contract is for a SERVICE AGREEMENT FOR SPECTRAMAX ID3 PLATE READER, with a ceiling value of $10,932.00 and a period of performance ending on July 14, 2026. The contract has no set-aside designation. Molecular Devices LLC is a manufacturer...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a SERVICE AGREEMENT FOR SPECTRAMAX M3 MULTI-MODE MICROPLATE READER. The potential value of the contract is $14,122.00 and the completion date is June 24, 2025. Molecular Devices LLC is a major provider of high-performance bioanalytical measurement solutions for life sciences...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Molecular Devices LLC, a for-profit limited liability company, to provide a SpectraMax M5-R microplate/cuvette reader. The $25,545.00 contract has a completion date of October 15, 2023 and does not have a set-aside designation. Molecular Devices is an experienced provider of bioanalytical measurement solutions,...
- <p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for a microplate reader on September 22, 2020, with a ceiling value of $24,987.78 and a firm fixed price. Work is performed in San Jose, California, with an ultimate completion date of October 30, 2020. No small business set-aside applies to this order.</p>
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,557.12 firm fixed price purchase order to Molecular Devices LLC for maintenance services. The contract has a period of performance from January 1, 2024 through December 31, 2024. Molecular Devices LLC will provide maintenance for equipment located at the NIH campus in Bethesda, Maryland in support of the NCI's research programs. No subcontractors or set aside designations were...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $64,000 purchase order to Meso Scale Discovery of Potomac, Maryland. Under the firm fixed price contract, Meso Scale Discovery will provide one Meso QuickPlex SQ 120mm plate reader to the agency by mid-November 2023. The National Cancer Institute, part of NIH within HHS, supports research on cancer causes, prevention, diagnosis, and treatment to contribute to its mission of leading the...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,711 purchase order to Molecular Devices LLC for maintenance services. Molecular Devices, located in Bethesda, Maryland, will provide maintenance under a firm fixed price contract to support the agency's research efforts. No subcontractors or set aside designations were identified. The award falls under HHS-NIH's efforts to advance cancer research and further the National Cancer...
- This is a $7,529.25 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for annual service and maintenance of the SpectraMax M2 microplate reader system used in NCI's research programs. The contract has an ultimate completion date of March 31, 2025 and was awarded on April 14, 2020. There is no set-aside designation for this award. Molecular Devices LLC is the prime contractor and...
- <p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $14,655.20 on June 4, 2020, to procure a SpectraMax ABS Plus UV/Vis single-mode microplate reader. Place of performance is San Jose, California. The order carries firm fixed price terms and was due for completion by July 3, 2020. No set-aside designation applied.</p>
- <p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $7,821.75 on March 14, 2019, with an ultimate completion date of March 14, 2020. The order is firm fixed price with no set-aside designation. Place of performance is Gaithersburg, Maryland. The purchase order was issued to de-obligate funds from FY2019 expiring lines in accordance with NIH Office of Administrative Law and Management communication.</p>